Holding M&M in your portfolio? Here's your silver lining!
Holding M&M in your portfolio? Here's your silver lining!

Holding M&M in your portfolio? Here's your silver lining!

M&M has very strong support in the zone of 750 -760 and hence it's not expected to fall much lower from the current levels.

DSIJ Intelligence Article rating: 4.8

How often do you see the stock of M&M slipping by more than 4 per cent especially when Sensex is up by 1 per cent, making fresh life-highs for itself? One might assume that there must be something seriously wrong with the stock to behave in such a manner!

These stocks should be on your watchlist today!
These stocks should be on your watchlist today!

These stocks should be on your watchlist today!

DSIJ Intelligence-3 Article rating: 5.0

IRB Infrastructure: Udaipur BOT Project implemented by Udaipur Tollway Ltd (now a part of IRB Infrastructure Trust Private InvIT) has been issued a completion certificate by the competent authority.

This high momentum, high PE supplier of automotive solutions is trending upwards!
This high momentum, high PE supplier of automotive solutions is trending upwards!

This high momentum, high PE supplier of automotive solutions is trending upwards!

As per the technical indicators such as MACD & RSI, Minda Industries is looking strong, and it is further expected to move up in the short term.

DSIJ Intelligence Article rating: 4.8

Minda Industries gave a breakout during Monday’s trading session after crossing Rs 578 levels with heavy volumes.  

FII buying push Nippon Life India Asset Management to 52-week high
FII buying push Nippon Life India Asset Management to 52-week high

FII buying push Nippon Life India Asset Management to 52-week high

The asset management companies are expected to do well in the coming future as the equity market performs exceedingly well and witness heavy investors’ participation.

DSIJ Intelligence Article rating: 4.8

Nippon Life India Asset Management (NAM) was amongst the top mid-cap gainers during Monday’s trading session. The stock gained by more than 6 per cent on a closing basis even as Sensex was up by only 1 per cent.   

Zydus Cadila trades flat despite getting nod for Fluphenazine Hydrochloride tablets
Zydus Cadila trades flat despite getting nod for Fluphenazine Hydrochloride tablets

Zydus Cadila trades flat despite getting nod for Fluphenazine Hydrochloride tablets

Fluphenazine Hydrochloride tablets are used in the treatment of a certain type of mental or mood-related condition (schizophrenia).

DSIJ Intelligence Article rating: 3.4

Zydus Cadila announced of receiving final approval from USFDA for marketing market Fluphenazine Hydrochloride tablets in the strengths of 1 mg, 2.5 mg, 5 mg, and 10 mg.  

RSS
First24502451245224532455245724582459Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR